ATI's aerospace demand, rising estimates, strategic nickel investments and strong cash flow make the stock a compelling portfolio addition.
On CNBC's June 18, 2026 segment, Tara Murphy Dougherty, CEO of Air (recently rebranded from Govini), delivered a blunt diagnosis of America's defense-industrial posture.
In the latest trading session, ATI (ATI) closed at $195.81, marking a -1.35% move from the previous day.
ATI (ATI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ATI extends its strategic material supply agreement with BWXT through fiscal 2030, supporting the U.S. Naval Nuclear Propulsion Program.
ATI shares are up 25% in three months as aerospace, defense and specialty energy demand rise and nickel alloy upgrades sharpen its edge.
Aclaris Therapeutics NASDAQ: ACRS executives outlined a busy clinical calendar for the biotechnology company during a fireside chat at the Jefferies 2026 Global Healthcare Conference, highlighting upcoming readouts across its immunology pipeline and a planned Phase 2 asthma study for its lead bispecific antibody.
ATI prices $450M of 5.875% senior notes due 2033, earmarking $350M to redeem its 2027 notes.
ATI notches a new 52-week high as Q1 EPS beats estimates and demand in aerospace, defense and specialty energy stays strong.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ATI Inc. (ATI) Presents at Bernstein 42nd Annual Strategic Decisions Conference Prepared Remarks Transcript
ATI (ATI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.